A real world study suggests found that more than three-quarters of participants receiving the anti-amyloid drug Leqembi either remained clinically stable or improved by one disease stage.
Continue reading at Medical News Today.
Alzheimer’s Drug Leqembi May Help Over 75% People Remain Stable Or …
